Figure 11.1 Trends in ESRD expenditures,

Slides:



Advertisements
Similar presentations
Chapter 4: Hospitalization 2014 A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.
Advertisements

Vol 2, ESRD, Ch ANNUAL DATA REPORT VOLUME 2: END-STAGE RENAL DISEASE Chapter 9: Costs of ESRD.
Chapter 3: Clinical Indicators and Preventive Care 2014 A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.
Chapter 2: Healthy People A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.
Chapter 6: Medicare Expenditures for CKD 2014 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
Chapter 2: Identification and Care of Patients With CKD 2014 ANNUAL DATA REPORT VOLUME 1: CHRONIC KIDNEY DISEASE.
Chapter 5: Mortality 2014 A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.
Chapter i: Introduction 2014 A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.
Chapter 3: Morbidity & Mortality 2014 ANNUAL DATA REPORT VOLUME 1: CHRONIC KIDNEY DISEASE.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 8: Pediatric ESRD.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 6: Mortality.
Chapter 2: Identification and Care of Patients With CKD 2015 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 7: Transplantation.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 9: Cardiovascular Disease in Patients With ESRD.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 3: Clinical Indicators and Preventive Care.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 11: Costs of ESRD.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 14: End-of-life Care for Patients with End-Stage Renal Disease:
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 10: Dialysis Providers.
Chapter 6: Medicare Expenditures for Persons with CKD 2015 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 12: Part D Prescription Drug Coverage in Patients with ESRD.
Chapter 5: Acute Kidney Injury 2015 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 5: Hospitalization.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 2: Healthy People 2020.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 4: Vascular Access.
2016 Annual Data Report, Vol 2, ESRD, Ch 13
2016 Annual Data Report, Vol 2, ESRD, Ch 5
Figure 3.1 ESRD clinical indicators, CROWNWeb data, December 2015
2016 Annual Data Report, Vol 2, ESRD, Introduction
Figure 9.1 Causes of death in ESRD patients,
UK Renal Registry 13th Annual Report
2016 Annual Data Report, Vol 2, ESRD, Ch 6
Figure 10.1 Dialysis unit counts, by unit affiliation, 2011–2014
Table 6.1 Prevalent Medicare fee-for-service patient counts and spending for beneficiaries aged 65 and older, by DM, CHF, and/or CKD, 2014 U.S. Medicare.
Chapter 2: Identification and Care of Patients With CKD
Volume 2: End-Stage Renal Disease
2016 Annual Data Report, Vol 1, CKD, Ch 2
Chapter 8: Cardiovascular Disease in Patients with ESRD
Chapter 6: Health Expenditures for Persons with CKD
Volume 2: End-Stage Renal Disease Chapter 4: Hospitalization
Chapter 12: End-of-life Care for Patients with ESRD:
Volume 2: End-Stage Renal Disease Chapter 6: Transplantation
December 31st point prevalent counts by modality figure 3.1
2016 Annual Data Report, Vol 2, ESRD, Ch 4
2016 Annual Data Report, Vol 2, ESRD, Ch 12
Volume 1: Chronic Kidney Disease Chapter 3: Morbidity and Mortality
Chapter 9: Healthcare Expenditures for Persons with ESRD
Chapter 2: Clinical Indicators and Preventive Care
2016 Annual Data Report, Vol 2, ESRD, Ch 14
Volume 2: End-Stage Renal Disease Chapter 4: Hospitalization
Chapter 6: CKD among Children and Adolescents
2016 Annual Data Report, Vol 1, CKD, Ch 3
Volume 2: End-Stage Renal Disease Chapter 6: Transplantation
Chapter 3: Morbidity and Mortality
Volume 2: End-Stage Renal Disease
Volume 2: End-Stage Renal Disease
Volume 2: End-Stage Renal Disease
Chapter 9: Healthcare Expenditures for Persons with ESRD
Chapter 2: Identification and Care of Patients with CKD
Chapter 8: Cardiovascular Disease in Patients with ESRD
Chapter 12: End-of-life Care for Patients with ESRD:
Chapter 7: Healthcare Expenditures for Persons with CKD
UK Renal Registry 16th Annual Report
In Reply to ‘The US Renal Data System “Pie Chart of Death”’
A Timely Evaluation of the Psychometric Properties of the KDQOL-36
UK Renal Registry 15th Annual Report
UK Renal Registry 14th Annual Report
Lynda Anne Szczech, Ira L. Lazar  Kidney International 
Worldwide incidence of ESRD figure 12.1, per million population
Figure 9.1.a Causes of death in ESRD patients,
Chapter 2: Identification and Care of Patients with CKD
Presentation transcript:

Figure 11.1 Trends in ESRD expenditures, 2004-2014 Data Source: USRDS ESRD Database; “Medicare paid” data were obtained from Reference Table K.1 and “Medicare patient obligation” data from special analyses. Abbreviation: ESRD, end-stage renal disease. 2016 Annual Data Report, Vol 2, ESRD, Ch 11

2016 Annual Data Report, Vol 2, ESRD, Ch 11 Figure 11.2 Trends in costs of the Medicare & ESRD programs, 2004-2014 Data Source: Total ESRD costs obtained from USRDS ESRD Database; Reference Table K.1. Total Medicare expenditures obtained from Trustees Report, Table II.B1 https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/ReportsTrustFunds/TrusteesReports.html. Abbreviation: ESRD, end-stage renal disease. 2016 Annual Data Report, Vol 2, ESRD, Ch 11

2016 Annual Data Report, Vol 2, ESRD, Ch 11 Figure 11.3 Trends in numbers of point prevalent ESRD patients, 2004-2014 Data Source: USRDS ESRD Database. December 31 point prevalent ESRD patients. Abbreviation: ESRD, end-stage renal disease. 2016 Annual Data Report, Vol 2, ESRD, Ch 11

Figure 11.4 Annual percent change in Medicare ESRD spending, 2004-2014 Data Source: USRDS ESRD Database; Reference Table K.4. Total Medicare ESRD costs from claims data; includes all claims with Medicare as primary payer only. Abbreviation: ESRD, end-stage renal disease. 2016 Annual Data Report, Vol 2, ESRD, Ch 11

2016 Annual Data Report, Vol 2, ESRD, Ch 11 Figure 11.5 Trends in total Medicare fee-for-service spending for ESRD, by type of service, 2004-2014 Data Source: USRDS ESRD Database; Reference Table K.1. Total Medicare costs from claims data. Abbreviation: ESRD, end-stage renal disease. 2016 Annual Data Report, Vol 2, ESRD, Ch 11

2016 Annual Data Report, Vol 2, ESRD, Ch 11 Figure 11.6 Total Medicare fee-for-service inpatient spending by cause of hospitalization, 2004-2014 Data Source: USRDS ESRD Database. Total Medicare costs from claims data. Abbreviation: ESRD, end-stage renal disease. Unknown hospitalization cost (<0.01%) was combined with ‘Other’. 2016 Annual Data Report, Vol 2, ESRD, Ch 11

Figure 11.7 Total Medicare ESRD expenditures, by modality, 2004-2014 Data Source: USRDS ESRD Database. Total Medicare costs from claims data for period prevalent ESRD patients. Abbreviation: ESRD, end-stage renal disease. 2016 Annual Data Report, Vol 2, ESRD, Ch 11

2016 Annual Data Report, Vol 2, ESRD, Ch 11 Figure 11.8 Total Medicare ESRD expenditures per person per year, by modality, 2004-2014 Data Source: USRDS ESRD Database; Reference Tables K.7, K.8, & K.9.Period prevalent ESRD patients; includes all claims with Medicare as primary payer only. Abbreviation: ESRD, end-stage renal disease. 2016 Annual Data Report, Vol 2, ESRD, Ch 11